Created in 2010 (United States), CLIVATUCYN own 6 sister brands and 2214 competing brands. CLIVATUCYN is a brand of Immunomedics, listed on the stock exchange of New York. CLIVATUCYN belongs to the Biotechnology business sector.

CLIVATUCYN is a brand of Immunomedics () Share price

Share price and profitability of the share Immunomedics (CLIVATUCYN)

Buy Immunomedics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Stock market history Immunomedics (CLIVATUCYN)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more